83_FR_12067 83 FR 12014 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting

83 FR 12014 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 53 (March 19, 2018)

Page Range12014-12015
FR Document2018-05458

Federal Register, Volume 83 Issue 53 (Monday, March 19, 2018)
[Federal Register Volume 83, Number 53 (Monday, March 19, 2018)]
[Notices]
[Pages 12014-12015]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-05458]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Board of Scientific 
Counselors, NIDDK.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in section 552b(c)(6), Title 5 
U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the National 
Institute of Diabetes and Digestive and Kidney Diseases, including 
consideration of personnel qualifications and performance, and the 
competence of individual investigators, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Board of Scientific Counselors, NIDDK.
    Date: April 19-20, 2018.
    Time: 8:00 a.m. to 4:30 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Building 10, Solarium 
Conference Room 9S233, 10 Center Drive, Bethesda, MD 20892.
    Contact Person: Michael W. Krause, Ph.D., Scientific Director, 
National Institute of Diabetes and Digestive and Kidney Diseases, 
National Institute of Health, Building 5, Room B104, Bethesda, MD 
20892-1818, (301) 402-4633, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)


[[Page 12015]]


    Dated: March 13, 2018.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-05458 Filed 3-16-18; 8:45 am]
 BILLING CODE 4140-01-P



                                                12014                         Federal Register / Vol. 83, No. 53 / Monday, March 19, 2018 / Notices

                                                MD 20892–7924, 301–827–7913, creazzotl@                 DEPARTMENT OF HEALTH AND                              (Catalogue of Federal Domestic Assistance
                                                mail.nih.gov.                                           HUMAN SERVICES                                        Program Nos. 93.306, Comparative Medicine;
                                                (Catalogue of Federal Domestic Assistance                                                                     93.333, Clinical Research, 93.306, 93.333,
                                                Program Nos. 93.233, National Center for                National Institutes of Health                         93.337, 93.393–93.396, 93.837–93.844,
                                                Sleep Disorders Research; 93.837, Heart and                                                                   93.846–93.878, 93.892, 93.893, National
                                                Vascular Diseases Research; 93.838, Lung                Center for Scientific Review; Notice of               Institutes of Health, HHS)
                                                Diseases Research; 93.839, Blood Diseases               Closed Meetings
                                                                                                                                                                Dated: March 12, 2018.
                                                and Resources Research, National Institutes               Pursuant to section 10(d) of the                    Sylvia L. Neal,
                                                of Health, HHS)                                         Federal Advisory Committee Act, as                    Program Analyst, Office of Federal Advisory
                                                  Dated: March 13, 2018.                                amended, notice is hereby given of the                Committee Policy.
                                                Michelle Trout,                                         following meetings.                                   [FR Doc. 2018–05454 Filed 3–16–18; 8:45 am]
                                                                                                          The meetings will be closed to the
                                                Program Analyst, Office of Federal Advisory                                                                   BILLING CODE 4140–01–P
                                                                                                        public in accordance with the
                                                Committee Policy.
                                                                                                        provisions set forth in sections
                                                [FR Doc. 2018–05456 Filed 3–16–18; 8:45 am]
                                                                                                        552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                BILLING CODE 4140–01–P                                  as amended. The grant applications and                DEPARTMENT OF HEALTH AND
                                                                                                        the discussions could disclose                        HUMAN SERVICES
                                                                                                        confidential trade secrets or commercial
                                                DEPARTMENT OF HEALTH AND                                                                                      National Institutes of Health
                                                                                                        property such as patentable material,
                                                HUMAN SERVICES                                          and personal information concerning                   National Institute of Diabetes and
                                                                                                        individuals associated with the grant                 Digestive and Kidney Diseases; Notice
                                                National Institutes of Health                           applications, the disclosure of which
                                                                                                                                                              of Closed Meeting
                                                                                                        would constitute a clearly unwarranted
                                                National Institute of Biomedical
                                                                                                        invasion of personal privacy.                           Pursuant to section 10(d) of the
                                                Imaging and Bioengineering; Notice of
                                                Closed Meeting                                            Name of Committee: Center for Scientific            Federal Advisory Committee Act, as
                                                                                                        Review Special Emphasis Panel; Pediatric              amended, notice is hereby given of a
                                                                                                        Immunotherapy Discovery and Development
                                                  Pursuant to section 10(d) of the                      Network (PI–DDN) (U01).
                                                                                                                                                              meeting of the Board of Scientific
                                                Federal Advisory Committee Act, as                        Date: April 9, 2018.                                Counselors, NIDDK.
                                                amended, notice is hereby given of the                    Time: 8:00 a.m. to 6:00 p.m.                          The meeting will be closed to the
                                                following meeting.                                        Agenda: To review and evaluate grant                public as indicated below in accordance
                                                                                                        applications.
                                                  The meeting will be closed to the                       Place: Sheraton Reston Hotel, 11810                 with the provisions set forth in section
                                                public in accordance with the                           Sunrise Valley Dr., Reston, VA 20191.                 552b(c)(6), Title 5 U.S.C., as amended
                                                provisions set forth in sections                          Contact Person: Malaya Chatterjee, Ph.D.,           for the review, discussion, and
                                                552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,              Scientific Review Officer, Center for                 evaluation of individual intramural
                                                as amended. The grant applications and                  Scientific Review, National Institutes of             programs and projects conducted by the
                                                                                                        Health, 6701 Rockledge Drive, Room 6192,
                                                the discussions could disclose                                                                                National Institute of Diabetes and
                                                                                                        MSC 7804, Bethesda, MD 20892, (301) 806–
                                                confidential trade secrets or commercial                2515, chatterm@csr.nih.gov.                           Digestive and Kidney Diseases,
                                                property such as patentable material,                     Name of Committee: Center for Scientific            including consideration of personnel
                                                and personal information concerning                     Review Special Emphasis Panel; Convergent             qualifications and performance, and the
                                                individuals associated with the grant                   Neuroscience: From Genomic Association to             competence of individual investigators,
                                                applications, the disclosure of which                   Causation.                                            the disclosure of which would
                                                would constitute a clearly unwarranted                    Date: April 10, 2018.                               constitute a clearly unwarranted
                                                                                                          Time: 11:00 a.m. to 5:00 p.m.
                                                invasion of personal privacy.                             Agenda: To review and evaluate grant
                                                                                                                                                              invasion of personal privacy.
                                                  Name of Committee: National Institute of              applications.                                           Name of Committee: Board of Scientific
                                                Biomedical Imaging and Bioengineering                     Place: National Institutes of Health, 6701          Counselors, NIDDK.
                                                Special Emphasis Panel; NIBIB BRAIN                     Rockledge Drive, Bethesda, MD 20892                     Date: April 19–20, 2018.
                                                Review, (2018/08).                                      (Virtual Meeting).                                      Time: 8:00 a.m. to 4:30 p.m.
                                                                                                          Contact Person: Jana Drgonova, Ph.D.,
                                                  Date: May 7, 2018.                                                                                            Agenda: To review and evaluate personal
                                                                                                        Scientific Review Officer, Center for
                                                  Time: 8:00 a.m. to 5:00 p.m.                          Scientific Review, National Institutes of             qualifications and performance, and
                                                  Agenda: To review and evaluate grant                  Health, 6701 Rockledge Drive, Room 5213,              competence of individual investigators.
                                                applications.                                           Bethesda, MD 20892, 301–827–2549,                       Place: National Institutes of Health,
                                                  Place: The William F. Bolger Center, 9600             jdrgonova@mail.nih.gov.                               Building 10, Solarium Conference Room
                                                Newbridge Drive, Potomac, MD 20854.                       Name of Committee: Center for Scientific            9S233, 10 Center Drive, Bethesda, MD 20892.
                                                  Contact Person: Ruixia Zhou, Ph.D.,                   Review Special Emphasis Panel; NIBIB                    Contact Person: Michael W. Krause, Ph.D.,
                                                Scientific Review Officer, 6707 Democracy               Trailblazer Award for New and Early Stage             Scientific Director, National Institute of
                                                Boulevard, Suite 957, Bethesda, MD 20892,               Investigators (R21).                                  Diabetes and Digestive and Kidney Diseases,
                                                (301) 496–4773, zhour@mail.nih.gov.                       Date: April 11, 2018.                               National Institute of Health, Building 5,
                                                                                                          Time: 1:00 p.m. to 3:00 p.m.                        Room B104, Bethesda, MD 20892–1818, (301)
                                                  Dated: March 13, 2018.                                  Agenda: To review and evaluate grant
                                                                                                                                                              402–4633, mwkrause@helix.nih.gov.
                                                                                                        applications.
sradovich on DSK3GMQ082PROD with NOTICES




                                                David Clary,
                                                                                                          Place: National Institutes of Health, 6701          (Catalogue of Federal Domestic Assistance
                                                Program Analyst, Office of Federal Advisory                                                                   Program Nos. 93.847, Diabetes,
                                                                                                        Rockledge Drive, Bethesda, MD 20892
                                                Committee Policy.                                                                                             Endocrinology and Metabolic Research;
                                                                                                        (Telephone Conference Call).
                                                [FR Doc. 2018–05457 Filed 3–16–18; 8:45 am]               Contact Person: Chee Lim, Ph.D., Scientific         93.848, Digestive Diseases and Nutrition
                                                BILLING CODE 4140–01–P                                  Review Officer, Center for Scientific Review,         Research; 93.849, Kidney Diseases, Urology
                                                                                                        National Institutes of Health, 6701 Rockledge         and Hematology Research, National Institutes
                                                                                                        Drive, Room 4128, Bethesda, MD 20892, 301–            of Health, HHS)
                                                                                                        435–1850, limc4@csr.nih.gov.



                                           VerDate Sep<11>2014   16:43 Mar 16, 2018   Jkt 244001   PO 00000   Frm 00061   Fmt 4703   Sfmt 4703   E:\FR\FM\19MRN1.SGM   19MRN1


                                                                              Federal Register / Vol. 83, No. 53 / Monday, March 19, 2018 / Notices                                                   12015

                                                  Dated: March 13, 2018.                                DEPARTMENT OF HEALTH AND                                Place: National Institutes of Health, Two
                                                David Clary,                                            HUMAN SERVICES                                        Democracy Plaza, 6707 Democracy
                                                                                                                                                              Boulevard, Bethesda, MD 20892 (Telephone
                                                Program Analyst, Office of Federal Advisory                                                                   Conference Call).
                                                Committee Policy.                                       National Institutes of Health
                                                                                                                                                                Contact Person: Thomas A. Tatham, Ph.D.,
                                                [FR Doc. 2018–05458 Filed 3–16–18; 8:45 am]
                                                                                                        National Institute of Diabetes and                    Scientific Review Officer, Review Branch,
                                                                                                                                                              DEA, NIDDK, National Institutes of Health,
                                                BILLING CODE 4140–01–P                                  Digestive and Kidney Diseases; Notice
                                                                                                                                                              Room 7021, 6707 Democracy Boulevard
                                                                                                        of Closed Meetings                                    Bethesda, MD 20892–5452, (301) 594–3993,
                                                                                                          Pursuant to section 10(d) of the                    tathamt@mail.nih.gov.
                                                DEPARTMENT OF HEALTH AND
                                                                                                        Federal Advisory Committee Act, as                      Name of Committee: National Institute of
                                                HUMAN SERVICES
                                                                                                        amended, notice is hereby given of the                Diabetes and Digestive and Kidney Diseases
                                                                                                        following meetings.                                   Special Emphasis Panel; PAR–17–123:
                                                National Institutes of Health                                                                                 Biomarkers for Diabetes and Digestive and
                                                                                                          The meetings will be closed to the
                                                                                                                                                              Kidney and Urologic Diseases Using
                                                National Institute of Neurological                      public in accordance with the                         Biorepository Samples (R01).
                                                Disorders and Stroke; Notice of                         provisions set forth in sections                        Date: May 7, 2018.
                                                Meetings                                                552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,              Time: 12:00 p.m. to 2:30 p.m.
                                                                                                        as amended. The grant applications and                  Agenda: To review and evaluate grant
                                                  Pursuant to section 10(d) of the                      the discussions could disclose                        applications.
                                                Federal Advisory Committee Act, as                      confidential trade secrets or commercial                Place: National Institutes of Health, Two
                                                                                                        property such as patentable material,                 Democracy Plaza, 6707 Democracy
                                                amended, notice is hereby given of the                                                                        Boulevard, Bethesda, MD 20892 (Telephone
                                                following meeting.                                      and personal information concerning
                                                                                                        individuals associated with the grant                 Conference Call).
                                                  The meeting will be closed to the                                                                             Contact Person: Najma S. Begum, Ph.D.,
                                                                                                        applications, the disclosure of which                 Scientific Review Officer, Review Branch,
                                                public in accordance with the                           would constitute a clearly unwarranted                DEA, NIDDK, National Institutes of Health,
                                                provisions set forth in sections                        invasion of personal privacy.                         Room 7349, 6707 Democracy Boulevard,
                                                552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,                                                                    Bethesda, MD 20892–5452, (301) 594–8894,
                                                                                                          Name of Committee: National Institute of
                                                as amended. The contract proposals and                  Diabetes and Digestive and Kidney Diseases            begumn@niddk.nih.gov.
                                                the discussions could disclose                          Special Emphasis Panel; Pediatric                       Name of Committee: National Institute of
                                                confidential trade secrets or commercial                Applications.                                         Diabetes and Digestive and Kidney Diseases
                                                property such as patentable material,                     Date: March 29, 2018.                               Special Emphasis Panel; PAR–18–012:
                                                and personal information concerning                       Time: 12:00 p.m. to 1:00 p.m.                       NIDDK Program Projects (P01) in Kidney
                                                                                                          Agenda: To review and evaluate grant                Diseases.
                                                individuals associated with the contract                applications.                                           Date: May 9, 2018.
                                                proposals, the disclosure of which                        Place: National Institutes of Health, Two             Time: 11:00 a.m. to 3:00 p.m.
                                                would constitute a clearly unwarranted                  Democracy Plaza, 6707 Democracy                         Agenda: To review and evaluate grant
                                                invasion of personal privacy.                           Boulevard, Bethesda, MD 20892 (Telephone              applications.
                                                                                                        Conference Call).                                       Place: National Institutes of Health, Two
                                                  Name of Committee: National Institute of                Contact Person: Ryan G. Morris, Ph.D.,              Democracy Plaza, 6707 Democracy
                                                Neurological Disorders and Stroke, Special              Scientific Review Officer, Review Branch,             Boulevard, Bethesda, MD 20892 (Telephone
                                                Emphasis Panel; NINDS Loan Repayment                    DEA, NIDDK, National Institutes of Health,            Conference Call).
                                                Program Review 2018.                                    Room 7015, 6707 Democracy Boulevard,                    Contact Person: Najma S. Begum, Ph.D.,
                                                  Date: April 27, 2018.                                 Bethesda, MD 20892–2542, 301–594–4721,                Scientific Review Officer, Review Branch,
                                                  Time: 9:00 a.m. to 5:00 p.m.                          ryan.morris@nih.gov.                                  DEA, NIDDK, National Institutes of Health,
                                                  Agenda: To review and evaluate contract                 This notice is being published less than 15         Room 7349, 6707 Democracy Boulevard,
                                                proposals.                                              days prior to the meeting due to the timing           Bethesda, MD 20892–5452, (301) 594–8894,
                                                  Place: National Institutes of Health,                 limitations imposed by the review and                 begumn@niddk.nih.gov.
                                                Neuroscience Center, 6001 Executive                     funding cycle.
                                                                                                                                                              (Catalogue of Federal Domestic Assistance
                                                Boulevard, Rockville, MD 20852 (Virtual                   Name of Committee: National Institute of            Program Nos. 93.847, Diabetes,
                                                Meeting).                                               Diabetes and Digestive and Kidney Diseases            Endocrinology and Metabolic Research;
                                                                                                        Special Emphasis Panel; Pilot Clinical                93.848, Digestive Diseases and Nutrition
                                                  Contact Person: Ernest Lyons, Ph.D.,                  Nephrology Applications.
                                                Scientific Review Officer, Scientific Review                                                                  Research; 93.849, Kidney Diseases, Urology
                                                                                                          Date: April 6, 2018.                                and Hematology Research, National Institutes
                                                Branch, NINDS/NIH/DHHS, Neuroscience                      Time: 2:00 p.m. to 3:00 p.m.                        of Health, HHS)
                                                Center, 6001 Executive Blvd., Suite 3204,                 Agenda: To review and evaluate grant
                                                MSC 9529, Bethesda, MD 20892–9529, 301                  applications.                                           Dated: March 13, 2018.
                                                496–4056, lyonse@ninds.nih.gov.                           Place: National Institutes of Health, Two           David Clary,
                                                                                                        Democracy Plaza, 6707 Democracy                       Program Analyst, Office of Federal Advisory
                                                (Catalogue of Federal Domestic Assistance
                                                                                                        Boulevard, Bethesda, MD 20892 (Telephone              Committee Policy.
                                                Program Nos. 93.853, Clinical Research                  Conference Call).
                                                Related to Neurological Disorders; 93.854,                Contact Person: Ryan G. Morris, Ph.D.,              [FR Doc. 2018–05459 Filed 3–16–18; 8:45 am]
                                                Biological Basis Research in the                        Scientific Review Officer, Review Branch,             BILLING CODE 4140–01–P
                                                Neurosciences, National Institutes of Health,           DEA, NIDDK, National Institutes of Health,
                                                HHS)                                                    Room 7015, 6707 Democracy Boulevard,
                                                                                                        Bethesda, MD 20892–2542, 301–594–4721,                DEPARTMENT OF HOMELAND
                                                  Dated: March 12, 2018.                                ryan.morris@nih.gov.
sradovich on DSK3GMQ082PROD with NOTICES




                                                Sylvia L. Neal,                                                                                               SECURITY
                                                                                                          Name of Committee: National Institute of
                                                Program Analyst, Office of Federal Advisory             Diabetes and Digestive and Kidney Diseases            [Docket No. DHS–2017–0071]
                                                Committee Policy.                                       Special Emphasis Panel; SBIR Phase II
                                                [FR Doc. 2018–05460 Filed 3–16–18; 8:45 am]             Exploratory Clinical Trials.                          Privacy Act of 1974; System of
                                                                                                          Date: April 9, 2018.                                Records
                                                BILLING CODE 4140–01–P                                    Time: 11:00 a.m. to 2:00 p.m.
                                                                                                          Agenda: To review and evaluate grant                AGENCY:Privacy Office, Department of
                                                                                                        applications.                                         Homeland Security.


                                           VerDate Sep<11>2014   16:43 Mar 16, 2018   Jkt 244001   PO 00000   Frm 00062   Fmt 4703   Sfmt 4703   E:\FR\FM\19MRN1.SGM   19MRN1



Document Created: 2018-03-17 04:25:12
Document Modified: 2018-03-17 04:25:12
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesApril 19-20, 2018.
FR Citation83 FR 12014 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR